Qiagen NV (XTER:QIA) Short Interest


XTER:QIA Qiagen NV XTER:QIA
71 GF Score
Price €34.57
GF Value €45.80
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Qiagen NV Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

XTER:QIA vs TWST, CRL, BLLN: Short Interest Comparison

For the Diagnostics & Research subindustry, Qiagen NV's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qiagen NV Short Interest vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's Short Interest distribution charts can be found below:

* The bar in red indicates where Qiagen NV's Short Interest falls into.


XTER:QIA
71GF Score
Qiagen NV XTER:QIA
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Qiagen NV (XTER:QIA) Overvalued in 2026?

Based on GuruFocus' analysis, Qiagen NV stock appears to be undervalued. The current stock price of €34.57 is trading 24.5% below its estimated GF Value™ of €45.80. GuruFocus considers Qiagen NV to be Modestly Undervalued.

Key valuation signals for XTER:QIA:

  • Short Interest:
  • GF Value™: €45.80 vs. price of €34.57 (24.5% below fair value)
  • GF Score™: 71/100 with 2 warning signs

No single metric tells the full story. See the XTER:QIA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Qiagen NV Business Description

Address Hulsterweg 82, Venlo, LI, NLD, 5912 PL
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
71GF Score

Get the complete analysis for XTER:QIA

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€34.57
Price
€45.80
GF Value